| Symptoms/Prognosis |
| Common Chromosomal Abnormalities |
 |
|
Immunophenotyping
Cell Markers |
|
| % Frequency of leukemias in adults |
|
| M0 |
 |
|
No particular abnormalities |
CD 13, CD 33, CD11c, CD34, HLA-DRMust be
reactive + for at least 1 marker to be classed as myeloid |
5% |
| M1 |
|
|
|
CD 11cCD 33, CD 34, HLA-DR |
10 - 20 % |
| M2 |
|
|
|
CD 13, CD 33CD 11c, CD 15, HLA-DR |
30 - 40 % |
| M3 |
|
|
T(15;17) |
CD13
CD33
+/- CD11b, CD15 |
10 -15 % |
| M4 |
|
|
|
CD 11b, CD 11c, CD13, CD14, CD15, CD 33,
CD 34, CD 36, HLA-DR |
10 - 15 % |
| M5 |
|
|
|
CD 13, CD14, CD 11b, CD 11c, CD 33, CD 34,HLA-DR |
M5a: 10 - 15 M5b: < 5 % |
| M6 |
|
|
|
Glycophorin ACD 33, CD 36, CD 71 |
5% |
| M7 |
|
|
|
Glycophorin A,CD 41a, CD 61
|
5% |
